J. Hartmann - Univ Tubingen Hosp | 人才画像

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 15 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Interim analysis of a cooperative registry to optimize neoadjuvant treatment for large sized, high grade nonrhabdomyo(soft tissue)sarcoma (NRSTS) following R0/1-resection (IAWS-1)

J. Hartmann, C. Hann von Weyhern, S. Kraus, R. Souchon, A. Koenigsrainer, T. Kluba,P. de Zwart, N. Frickhofen,A. Wolff,F. Fend,V. Budach

ONKOLOGIEno. SUPnan (2010): 186-186

引用0浏览0引用

Neoadjuvant Therapy for colorectal Liver metastases with Cetuximab and FOLFOX or Cetuximab and FOLFIRI - Address and Resection

G. Folprecht,T. Gruenberger,W. O. Bechstein,H-R Raab,F. Lordick,J. Hartmann, H. Lang,A. Frilling, J. Stoehlmacher,J. Weitz,R. Konopke,C. Stroszczynski,

ONKOLOGIE（2010）

引用0浏览0引用

Final analysis of a non-comparative phase II study of multi target enzyme inhibitor pemetrexed in patients with refractory soft tissue sarcoma - German Sarcoma Group AIO 005

J. Hartmann,S. Bauer, S. Schaedel, I. Meisinger, B. Kasper,H. -G. Kopp,F. Mayer, V. Gruenwald

ONKOLOGIEno. SUPnan (2010): 53-53

引用0浏览0引用

RESULTS FROM THE CELIM STUDY: CETUXIMAB PLUS FOLFOX6 OR CETUXIMAB PLUS FOLFIRI AS NEOADJUVANT TREATMENT FOR NONRESECTABLE COLORECTAL CANCER LIVER METASTASES

C. Koehne,T. Gruenberger,W. Bechstein,J. Hartmann, H. Lang,F. Lordick,T. Herrmann,J. Stoehlmacher,A. Frilling,H. Raab, T. Liersch,D. Ockert,

ANNALS OF ONCOLOGY（2009）

引用3浏览0引用

7165 The value of PET/CT with F-18-FLT and F-18-FDG in the therapeutic management of metastatic germ cell tumours

J. Hartmann,P. Aschoff,H. Dittmann,F. Mayer,G. Reischl,C. Claussen,R. Bares,C. Pfannenberg

EJC SUPPLEMENTS（2009）

引用0浏览0引用

Preoperative FDG-PET-CT correlates with intraoperative findings in patients with peritoneal carcinomatosis

I. Koenigsrainer, P. Aschoff, S. Beckert, D. Zieker,J. Hartmann,C. Pfannenberg, S. Miller, S. Coerper, B. Bruecher, A. Koenigsrainer

ONKOLOGIEno. SUPnan (2008): 80-80

引用0浏览0引用

Selektion zur Peritonektomie mit hyperthermer intraoperativer Chemotherapie (HIPEC) bei Peritonealkarzinose

I. Königsrainer,P. Aschoff,D. Zieker,S. Beckert,J. Glatzle,C. Pfannenberg, S. Miller,J. Hartmann,T. Schroeder,B. Brücher,A. Königsrainer

ZENTRALBLATT FUR CHIRURGIE（2008）

引用18浏览0引用

The opus study: Predictive value of KRAS status on clinical outcome in patients with metastatic colorectal cancer treated with either FOLFOX4 or FOLFOX4 plus cetuximas

G. Schuch,I Bondarenko,J. Hartmann,F. De Braud,C. Volovat,J. Nippgen,C. Stroh,I Celik,P. Koralewski, C. Bokemeyer

ANNALS OF ONCOLOGY（2008）

引用0浏览0引用

Risk of radiation-induced Sarcome: Data of a population-based registry of 29 931 irradiated patients

J. Hartmann, H. Hecker,H. -G. Kopp,F. Mayer, B. Bruecher,J. Classen, L. Kanz, G. Ziemer, A. Koenigsrainer, D. Wallwiener,M. Bamberg

ONKOLOGIEno. SUPnan (2008): 175.0-175

引用0浏览0引用

The benefit of adjuvant chemotherapy in colon carcinoma UICC stage III depends on surgical quality. Results of the intact I trial

I. Konigsrainer, P. Aschoff, S. Beckert, D. Zieker,J. Hartmann,C. Pfannenberg, S. Miller, S. Coerper,B. Brucher, A. Konigsrainer

ONKOLOGIEno. SUPnan (2008): 80-81

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn